Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | F3 | P13726 | 4/20 | 1.00 |
| ▸ | SIRT5 | Q9NXA8 | 3/20 | 1.00 |
| ▸ | CYP3A4 | P08684 | 1/20 | 1.00 |
| ▸ | MAPK1 | P28482 | 1/20 | 1.00 |
| ▸ | OXTR | P30559 | 1/20 | 1.00 |
| ▸ | AVPR1A | P37288 | 1/20 | 1.00 |
| ▸ | CD81 | P60033 | 1/20 | 1.00 |
| ▸ | PTPN1 | P18031 | 8/20 | 0.75 |
| ▸ | PTPN2 | P17706 | 4/20 | 0.75 |
| ▸ | POLB | P06746 | 3/20 | 0.75 |
| ▸ | PTPN6 | P29350 | 3/20 | 0.75 |
| ▸ | RELA | Q04206 | 3/20 | 0.75 |
| ▸ | PSMB11 | A5LHX3 | 2/20 | 0.75 |
| ▸ | PSMA7 | O14818 | 2/20 | 0.75 |
| ▸ | AKR1B10 | O60218 | 2/20 | 0.75 |
| ▸ | PLA2G1B | P04054 | 2/20 | 0.75 |
| ▸ | PTPRC | P08575 | 2/20 | 0.75 |
| ▸ | PTPRF | P10586 | 2/20 | 0.75 |
| ▸ | PSMB1 | P20618 | 2/20 | 0.75 |
| ▸ | CES1 | P23141 | 2/20 | 0.75 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Echinocystic Acid SCHEMBL741321 | 1.00 | F3 (1.00) | F3SIRT5CYP3A4MAPK1OXTR | |
| Echinocystic Acid SCHEMBL30467147 | 1.00 | F3 (1.00) | F3SIRT5CYP3A4MAPK1OXTR | |
| Echinocystic Acid SCHEMBL18712289 | 1.00 | F3 (1.00) | F3SIRT5CYP3A4MAPK1OXTR | |
| Echinocystic Acid SCHEMBL4454760 | 1.00 | F3 (1.00) | F3SIRT5CYP3A4MAPK1OXTR | |
| Echinocystic Acid SCHEMBL13629642 | 1.00 | F3 (1.00) | F3SIRT5CYP3A4MAPK1OXTR | |
| Echinocystic Acid SCHEMBL18712288 | 1.00 | F3 (1.00) | F3SIRT5CYP3A4MAPK1OXTR | |
| Echinocystic Acid SCHEMBL18704435 | 1.00 | F3 (1.00) | F3SIRT5CYP3A4MAPK1OXTR | |
| Echinocystic Acid SCHEMBL17030511 | 1.00 | F3 (1.00) | F3SIRT5CYP3A4MAPK1OXTR | |
| Echinocystic Acid SCHEMBL21892162 | 1.00 | F3 (1.00) | F3SIRT5CYP3A4MAPK1OXTR | |
| Echinocystic Acid SCHEMBL30168683 | 1.00 | F3 (1.00) | F3SIRT5CYP3A4MAPK1OXTR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 507 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4652450-A1 | METHODS OF QUANTIFYING SAPONINS PRESENT IN PARTICLES COMPRISING SAPONIN AND LIPID | Novavax AB (SE) | 2025-11-26 | — | — | EP | claimed |
| US-20250346914-A1 | SAPONARIOSIDE BIOSYNTHETIC ENZYMES | PLANT BIOSCIENCE LTD (GB) | 2025-11-13 | — | — | US | claimed |
| EP-4615506-A1 | USE OF GSK-3 ACTIVATIOR TO MODULATE PROTEASOME ACTIVITY TO PREVENT AGEING ASSOCIATED CONDITIONS AND DISEASES | Sahin, Fikret (TR) | 2025-09-17 | — | — | EP | claimed |
| EP-4547833-A1 | SAPONARIOSIDE BIOSYNTHETIC ENZYMES | Plant Bioscience Limited (GB) | 2025-05-07 | — | — | EP | claimed |
| CN-119546753-A | Saponin biosynthetic enzymes | 植物生物科学有限公司 | 2025-02-28 | — | — | CN | claimed |
| CN-119165087-A | Method for detecting multiple components in rhizoma coptidis green particles | 上海市第七人民医院(上海中医药大学附属第七人民医院) | 2024-12-20 | — | — | CN | claimed |
| WO-2024258363-A1 | USE OF GSK-3 ACTIVATIOR TO MODULATE PROTEASOME ACTIVITY TO PREVENT AGEING ASSOCIATED CONDITIONS AND DISEASES | SAHIN FIKRET (TR) | 2024-12-19 | — | — | WO | claimed |
| CN-119074745-A | Hedera helix saponin composition, hedera helix leaf extract comprising the composition and application thereof | 浙江康恩贝中药有限公司 | 2024-12-06 | — | — | CN | claimed |
| CN-118901366-A | Fertilizing method for realizing multi-economic target yield increase of gleditsia sinensis | 山西省林业和草原科学研究院 | 2024-11-08 | — | — | CN | claimed |
| CN-118702759-A | Echinocystic acid derivative and preparation method and application thereof | 延边大学 | 2024-09-27 | — | — | CN | claimed |
| US-20070014739-A1 | Compositions and methods for controlling biofilms and bacterial infections | SEQUOIA SCIENCES, INC. | 2007-01-18 | — | — | US | claimed |
| WO-2006019881-A2 | COMPOSITIONS AND METHODS FOR CONTROLLING BIOFILMS AND BACTERIAL INFECTIONS | ELDRIDGE GARY R (US) | 2006-02-23 | — | — | WO | claimed |
| CN-1216896-C | Echinocystic acid preparation, medicinal preparation and new use as medicine | TIANYAO SCIENCE TECHNOLOGY CO (CN) | 2005-08-31 | — | — | CN | claimed |
| CN-1438237-A | Echinocystic acid preparation, medicinal preparation and new use as medicine | TIANYAO SCIENCE TECHNOLOGY CO (CN) | 2003-08-27 | — | — | CN | claimed |
| JP-2001527390-A | — | — | 2001-12-25 | — | — | JP | claimed |
| EP-1011655-A1 | INHIBITORS OF LEADERLESS PROTEIN EXPORT | Ciblex Corporation (US) | 2000-06-28 | — | — | EP | claimed |
| CN-1252716-A | Inhibitors of leaderless protein export | CIBLEX CORP (US) | 2000-05-10 | — | — | CN | claimed |
| WO-1998037880-A1 | INHIBITORS OF LEADERLESS PROTEIN EXPORT | CIBLEX CORPORATION (US) | 1998-09-03 | — | — | WO | claimed |
| EP-0317453-B1 | MEDICINAL COMPOSITIONS BASED ON FLAVONOIDS AND SAPONINS EXTRACTED FROM CHRYSANTHELLUM, PROCESS FOR THEIR MANUFACTURE AND THERAPEUTICAL USES | IPHYM SA Société Anonyme dite : (FR) | 1993-02-03 | — | — | EP | claimed |
| US-4146615-A | GLYCOSIDE OF ECHINOCYSTIC ACID, ANALGESIC, ANTIINFLAMMATORY, ANTIULCER | LABORATOIRES SARGET (FR) | 1979-03-27 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070014739-A1 | Compositions and methods for controlling biofilms and bacterial infections | RHOA, ALOX5, BLVRB | F3 91/4885SIRT5 981/4885CYP3A4 2860/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.